lung cancer
Conditions
Interventions
Experimental group:electroacupuncture
Sponsors
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. No other serious complications occurred in the patients with lung tumor who underwent thoracoscopic lobectomy or pneumonectomy; 2. Aged 60 to 85 years, ASA I-III, no gender restriction; 3. Patients who have completed auxiliary examination and have no immune system diseases; 4. Those who understand and agree to participate in the study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Arrhythmia before operation; 2. The patients with thyroid dysfunction before operation; 3. Taken within 1 month before operation ß- Receptor blockers and digitalis; 4. History of cardiothoracic surgery; 5. The patients with nerve injury of upper limb or lower extremity; 6. Patients with skin infection in the acupoints; 7. Patients with acupuncture and moxibustion treatment history; 8. Patients who cannot cooperate with the completion of the research plan, including language difficulties, infectious diseases and other medical history; 9. Participated in other clinical trials in the past four weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of new onset atrial fibrillation within 72 hours after surgery; | — |
Countries
China
Contacts
Public ContactZhou Zhengqing
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Outcome results
None listed